Vascular calcification: The three-hit model

Journal of the American Society of Nephrology

Volumn 20, Issue 6, 2009, Pages 1162-1164

  Moe, Sharon M ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FETUIN A; GLYCOPROTEIN; INHIBITOR PROTEIN; PHOSPHATE BINDING AGENT;

AGE; ARTERY CALCIFICATION; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; EDITORIAL; ENDOTHELIAL DYSFUNCTION; HEMODIALYSIS PATIENT; HUMAN; HYPERPHOSPHATEMIA; HYPERTENSION; INFLAMMATION; METABOLIC INHIBITION; MINERALIZATION; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; RISK ASSESSMENT;

EID: 67449099278     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2009040409     Document Type: Editorial

References (13)

1. Moe SM, Chen NX: Mechanisms of vascular calcification in chronic kidney disease. J Am Soc Nephrol 19: 213-216, 2008 (Pubitemid 351240642)
2. Pletcher MJ, Tice JA, Pignone M, Browner WS: Using the coronary artery calcium score to predict coronary heart disease events: A systematic review and meta-analysis. Arch Intern Med 164: 1285-1292, 2004 (Pubitemid 38828878)
3. Block GA, Raggi P, Bellasi A, Kooienga L, Spiegel DM: Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 71: 438-441, 2007 (Pubitemid 46303553)
4. London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H: Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18: 1731-1740, 2003 (Pubitemid 37098542)
5. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G: Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386: 78-81, 1997 (Pubitemid 27130923)
6. Schinke T, Karsenty G: Vascular calcification: A passive process in need of inhibitors. Nephrol Dial Transplant 15: 1272-1274, 2000 (Pubitemid 30705904)
7. Gangneux C, Daveau M, Hiron M, Derambure C, Papaconstantinou J, Salier JP: The inflammation-induced down-regulation of plasma fetuin- A (alpha2HS-Glycoprotein) in liver results from the loss of interaction between long C/EBP isoforms at two neighbouring binding sites. Nucleic Acids Res 31: 5957-5970, 2003 (Pubitemid 37442322)
8. Hermans MM, Brandenburg V, Ketteler M, Kooman JP, van der Sande FM, Boeschoten EW, Leunissen KM, Krediet RT, Dekker FW: Association of serum fetuin-A levels with mortality in dialysis patients. Kidney Int 72: 202-207, 2007 (Pubitemid 47067382)
9. Moe SM, Reslerova M, Ketteler M, O'Neill K, Duan D, Koczman J, Westenfeld R, Jahnen-Dechent W, Chen NX: Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int 67: 2295-2304, 2005 (Pubitemid 41623389)
10. Schafer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, Floege J, Muller-Esterl W, Schinke T, Jahnen-Dechent W: The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112: 357-366, 2003 (Pubitemid 38063764)
11. Schinke T, Amendt C, Trindl A, Poschke O, Muller-Esterl W, Jahnen- Dechent W: The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells: A possible role in mineralization and calcium homeostasis. J Biol Chem 271: 20789-20796, 1996 (Pubitemid 26281865)
12. Westenfeld R, Schafer C, Smeets R, Brandenburg VM, Floege J, Ketteler M, Jahnen-Dechent W: Fetuin-A (AHSG) prevents extraosseous calcification induced by uraemia and phosphate challenge in mice. Nephrol Dial Transplant 22: 1537-1546, 2007 (Pubitemid 47073751)
13. Westenfeld R, Schäfer C, Krüger T, Haarmann C, Schurgers LJ, Reutelingsperger C, Ivanovski O, Drueke T, Massy ZA, Ketteler M, Floege J, Jahnen-Dechent W: Fetuin-A protects against atherosclerotic calcification in CKD. J Am Soc Nephrol 20: 1264-1274, 2009